Implicating chromosomal aberrations with meningioma growth and recurrence: Results from FISH and MIB-I analysis of grades I and II meningioma tissue

Journal of Neuro-Oncology

Volumn 87, Issue 1, 2008, Pages 43-50

  Pfisterer, Wolfgang K ^a,b   Coons, Stephen W ^a   Aboul Enein, Fahmy ^b   Hendricks, William P ^a   Scheck, Adrienne C ^a   Preul, Mark C ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b Wiener Krankenanstaltenverbund   (Austria)

Author keywords

Chromosomal aberration; Fluorescent in situ hybridization (FISH); Meningioma; MIB 1; Tumor recurrence

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHROMOSOME 14Q; CHROMOSOME 1P; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CLINICAL DECISION MAKING; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PREDICTION; PROGNOSIS; RISK ASSESSMENT; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; CHROMOSOME ABERRATIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 38649083436     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-007-9498-9     Document Type: Article

References (36)

1. Kujas M (1993) Meningioma. Curr Opin Neurol 6:882-887
2. Perry A, Stafford SL, Scheithauer BW et al (1997) Meningioma grading: An analysis of histologic parameters. Am J Surg Pathol 21:1455-1465
3. Perry A, Scheithauer BW, Stafford SL et al (1999) "Malignancy" in meningiomas: A clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046-2056
4. Louis DN, Scheithauer BW, Budka H et al (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system: World health organisation classification of tumours. IARC Press, Lyon, pp 176-184
5. Puchner MJ, Fischer-Lampsatis RC, Herrmann HD, Freckmann N (1998) Suprasellar meningiomas-neurological and visual outcome at long-term follow-up in a homogeneous series of patients treated microsurgically. Acta Neurochir (Wien) 140:1231-1238
6. Adegbite AB, Khan MI, Paine KW, Tan LK (1983) The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51-56
7. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurochem 20:22-39
8. Marks SM, Whitwell HL, Lye RH (1986) Recurrence of meningiomas after operation. Surg Neurol 25:436-440
9. Perry A, Stafford SL, Scheithauer BW et al (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
10. Nagashima G, Aoyagi M, Wakimoto H et al (1995) Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Neurosurgery 37:478-482
11. Bitzer M, Opitz H, Popp J et al (1998) Angiogenesis and brain oedema in intracranial meningiomas: Influence of vascular endothelial growth factor. Acta Neurochir (Wien) 140:333-340
12. Goldman CK, Bharara S, Palmer CA et al (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40:1269-1277
13. Prayson RA (2005) The utility of MIB-1/Ki-67 immunostaining in the evaluation of central nervous system neoplasms. Adv Anat Pathol 12:144-148
14. Ho DM, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: A proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:1538-1547
15. Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors. Hum Pathol 29:1420-1427
16. Moller ML, Braendstrup O (1997) No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34:241-246
17. Cai DX, Banerjee R, Scheithauer BW et al (2001) Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: Diagnostic and prognostic implications. J Neuropathol Exp Neurol 60:628-636
18. Ishino S, Hashimoto N, Fushiki S et al (1998) Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer 83:360-366
19. Yakut T, Bekar A, Doygun M et al (2002) Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique. Teratog Carcinog Mutagen 22:217-225
20. Leone PE, Bello MJ, de Campos JM et al (1999) NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 18:2231-2239
21. Ueki K, Wen-Bin C, Narita Y et al (1999) Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas. Cancer Res 59:5995-5998
22. Al Mefty O, Kadri PA, Pravdenkova S et al (2004) Malignant progression in meningioma: Documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218
23. Coons SW, Johnson PC, Pearl DK (1997) The prognostic significance of Ki-67 labeling indices for oligodendrogliomas. Neurosurgery 41:878-884
24. Pfisterer WK, Hank NC, Preul MC et al (2004) Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas. Neurooncol 6:290-299
25. Pfisterer WK, Hendricks WP, Scheck AP et al (2007) Fluorescent in situ hybridization and ex vivo 1H MR spectroscopic examinations of meningioma tumor tissue: Is it possible to identify a clinically-aggressive subset of benign meningiomas? Neurosurgery 61:1048-1061
26. Matsuno A, Fujimaki T, Sasaki T et al (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504-510
27. Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242
28. Ketter R, Henn W, Niedermayer I et al (2001) Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: A retrospective study of 198 cases. J Neurosurg 95:601-607
29. Maillo A, Diaz P, Sayagues JM et al (2001) Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patients. Cancer 92:377-385
30. Zattara-Cannoni H, Gambarelli D, Dufour H et al (1998) Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors. Ann Genet 41:164-175
31. Leuraud P, Marie Y, Robin E et al (2000) Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas. J Neurooncol 50:207-213
32. Zang KD (2001) Meningioma: A cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93:207-220
33. Sayagues JM, Tabernero MD, Maillo A et al (2002) Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes. Cytometry 50:153-159
34. Cerda-Nicolas M, Lopez-Gines C, Perez-Bacete M et al (2000) Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: A study of 60 tumors. J Neurooncol 47:99-108
35. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202
36. Wilson CB (1994) Meningiomas: Genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg 81:666-675